The pharmaceutical industry operates under stringent regulatory expectations to ensure that drug products are consistently produced and controlled to meet quality standards appropriate for their intended use. Good Manufacturing Practices (GMP) form the backbone of these expectations, governing everything from facility design and equipment qualification to documentation, training, and quality oversight.
Quality Assurance (QA) serves as the overarching system that ensures GMP compliance is not only achieved but sustained. It integrates processes, procedures, and behaviors to prevent errors, ensure data integrity, and maintain product quality throughout the lifecycle. As regulatory scrutiny increases globally and supply chains become more complex, organizations must strengthen their QA systems and deepen their understanding of GMP principles to remain compliant and competitive.
This 60-minute webinar provides a focused and practical overview of Quality Assurance (QA) and Good Manufacturing Practices (GMP) as they apply to drug production environments. The session is designed to bridge the gap between regulatory requirements and day-to-day operational execution, emphasizing how quality systems function in real manufacturing settings.
The webinar begins with a foundational overview of GMP principles, including their regulatory basis and global alignment across agencies such as the FDA and EMA. Participants will gain a clear understanding of how GMP requirements translate into operational controls within pharmaceutical manufacturing, including facility design, equipment qualification, process validation, and environmental control.
The session then transitions into the role of Quality Assurance, highlighting how QA systems govern and oversee GMP compliance. This includes batch record review, deviation management, CAPA systems, change control, and internal audits. Special emphasis is placed on the concept that QA is not a department but a system that integrates across all functions.
A critical portion of the webinar focuses on documentation and data integrity. Participants will explore the principles of ALCOA+ and how poor documentation practices can lead to significant compliance risks. Real-world examples will illustrate how seemingly minor errors can escalate into regulatory findings.
The webinar also addresses human factors in GMP environments, including the role of training, behavior, and organizational culture in maintaining compliance. Participants will learn how operational discipline, procedural adherence, and effective training programs contribute directly to product quality and inspection readiness.
Finally, the session covers inspection readiness and regulatory expectations. Attendees will gain insight into how inspectors evaluate GMP systems, what they look for during inspections, and how to prepare effectively. The webinar concludes with practical strategies for strengthening QA systems and sustaining compliance in evolving regulatory landscapes.
